earn	wall street stocks marion labs mkc marion laboratories inc stock rose sharply today company presented bullish earnings scenario meeting for pharmaceutical analysts monday traders and analysts company expects earnings for fiscal ending june rise pct year ago that pronouncement encouraged analyst david crossen sanford bernstein and raise earnings estimates for company dlrs share compared previous estimate dlrs share last year company earned cts share marion stock gained meeting pharmaceutical analysts marion president fred lyons wall street eanrings estimates dlrs share for fiscal expected even aggressive side this range cts low lyons strong performance second half this year will result fourth quarter introduction and cardizem tablets analyst crossen that cardizem treats angina expected approved for treatment hypertension end year crossen marion small company growth cardizem big impact bottom line raised fiscal earnings estimates dlrs share previous estimate dlrs share company broad product pipeline industry and concerned innovative company business for years crossen expects marion growth rate pct InformationRetrieval.reuter